For diabetic patients, it could go from 365 to just 52 injections of insulin in a year. A real revolution in therapy seems to be near for the 500 million diabetic patients worldwide, over 3.5 million people in Italy. A new weekly basal insulin offers the same efficacy as existing daily insulins in patients with type 2 diabetes who have not used insulin before.
Intermittent fasting, if you eat in the morning it could prevent diabetes 2 by Elvira Naselli 06 May 2023
This is confirmed by two different studies published in Jama and in the New England Journal of Medicine. “This new molecule has the potential to simplify the therapy of diabetes that requires insulin therapy, eliminating the inconvenience of daily injections for patients and thus increasing adherence to insulin therapy. A real epochal change and a marked improvement in patients’ quality of life diabetics,” he explains Roberto Trevisan, professor of Endocrinology at the University of Milano-Bicocca and director of Diabetology at the ASST Papa Giovanni XXIII of Bergamo, the only Italian researcher who participated in the final draft of the study in the New England Journal of Medicine. Trevisan reports that the approval of the new molecule by the regulatory bodies of the drug is now awaited in order to make it available.
Type 1 diabetes, the story of Jessica Zanardo: “The onset is the most difficult moment, for this I help those who get sick” by Cinzia Lucchelli 15 April 2023
The transition from daily to weekly intake represents a great advantage for type 2 diabetics, who are often elderly subjects, with multiple pathologies, and who must take different therapies on a daily basis. Another advantage of formulating the therapy on a weekly basis is the possibility of reducing the commitment required of healthcare professionals who deal with diabetics who require insulin, especially for those admitted to long-term residential healthcare facilities.
From diabetes to osteoporosis, for every disease the doctor prescribes the right sport by Irma D’Aria 24 June 2023 Topics